View Older Stories View More Recent Stories

Jan 26, 2018 02:37PM Form SC 13D/A Adaptimmune Therapeutics Filed by: ORBIMED ADVISORS LLC
Jan 26, 2018 02:21PM Form SC 13D/A Arsanis, Inc. Filed by: ORBIMED ADVISORS LLC
Jan 26, 2018 12:23PM Form SC 13D/A ALPINE IMMUNE SCIENCES, Filed by: ORBIMED ADVISORS LLC
Jan 26, 2018 12:12PM Form SC 13D/A Nabriva Therapeutics Filed by: ORBIMED ADVISORS LLC
Jan 26, 2018 12:05PM Form SC 13D/A Clementia Pharmaceutical Filed by: ORBIMED ADVISORS LLC
Jan 26, 2018 11:51AM Form SC 13D/A PIERIS PHARMACEUTICALS, Filed by: ORBIMED ADVISORS LLC
Jan 26, 2018 06:04AM Form SC 13D/A ALPINE IMMUNE SCIENCES, Filed by: ORBIMED ADVISORS LLC
Jan 26, 2018 06:04AM Form SC 13D/A Clementia Pharmaceutical Filed by: ORBIMED ADVISORS LLC
Jan 26, 2018 06:04AM Form SC 13D/A PIERIS PHARMACEUTICALS, Filed by: ORBIMED ADVISORS LLC
Jan 26, 2018 06:04AM Form SC 13D/A Nabriva Therapeutics Filed by: ORBIMED ADVISORS LLC
Jan 25, 2018 08:51PM Form 3 resTORbio, Inc. For: Jan 25 Filed by: ORBIMED ADVISORS LLC
Jan 25, 2018 05:59PM Form 3 ORBIMED ADVISORS LLC For: Jan 25 Filed by: ARMO BioSciences, Inc.
Jan 24, 2018 09:00PM Form 4 Kala Pharmaceuticals, For: Jan 12 Filed by: ORBIMED ADVISORS LLC
Jan 23, 2018 10:00AM Skyhawk Therapeutics Launches With $8 Million in Seed Financing to Advance Its Novel Platform and Portfolio of Small Molecules That Correct RNA Expression
Jan 17, 2018 05:20PM Form SC 13D/A Xtant Medical Holdings, Filed by: ORBIMED ADVISORS LLC
Jan 17, 2018 08:38AM PlacementTracker Publishes 2017 PIPE and Private Placement Markets League Tables
Jan 12, 2018 05:03PM Form SC 13G Kala Pharmaceuticals, Filed by: ORBIMED ADVISORS LLC
Jan 5, 2018 03:15PM Form SC 13D/A PIERIS PHARMACEUTICALS, Filed by: ORBIMED ADVISORS LLC
Jan 4, 2018 07:27AM Neurogastrx, Inc. Raises $45M Series A To Bring Lead GI Candidate Through Proof Of Concept
Dec 20, 2017 08:30AM ORIC Has Appointed Rich Heyman, PhD as Acting Chief Executive Officer and Leonard Reyno, MD as Chief Medical Officer
Dec 13, 2017 07:30AM Pionyr Immunotherapeutics Completes $62 Million Series B Financing to Advance Antibody-based Therapeutics Targeting the Tumor Microenvironment
Dec 7, 2017 08:08PM OrbiMed Founder, Samuel D. Isaly, to Step Down
Dec 5, 2017 08:00AM PMV Pharma Appoints Winston Kung as COO & CFO
Dec 5, 2017 07:30AM Goldfinch Bio Appoints Anthony Johnson, M.D., President and Chief Executive Officer, and Michael Broxson, Chief Business and Operating Officer
Dec 1, 2017 12:40PM Form SC 13D scPharmaceuticals Inc. Filed by: ORBIMED ADVISORS LLC
Nov 30, 2017 02:51PM Form SC 13D Arsanis, Inc. Filed by: ORBIMED ADVISORS LLC
Nov 20, 2017 04:28PM Form SC 13D/A Loxo Oncology, Inc. Filed by: ORBIMED ADVISORS LLC
Nov 14, 2017 05:20PM Form 13F-HR ORBIMED ADVISORS LLC For: Sep 30
Nov 13, 2017 04:05PM Alpine Immune Sciences Reports Corporate Update and Third Quarter 2017 Financial Results
Nov 8, 2017 04:05PM Natera Reports Third Quarter 2017 Financial Results
Nov 8, 2017 03:52PM Form SC 13D/A Intellia Therapeutics, Filed by: ORBIMED ADVISORS LLC
Nov 1, 2017 02:20PM Inspire Medical Systems Ranks #2 on Cleveland Clinic’s List of the Top 10 Medical Innovations for 2018
Oct 27, 2017 12:03PM Form SC 13D/A ViewRay, Inc. Filed by: ORBIMED ADVISORS LLC
Oct 27, 2017 08:35AM ORIC Pharmaceuticals Announces First Subject Dosed in Phase 1 Clinical Study of Novel GR Antagonist with Planned Development for Oncology
Oct 20, 2017 04:18PM Form SC 13D RHYTHM PHARMACEUTICALS, Filed by: ORBIMED ADVISORS LLC
Oct 17, 2017 07:00AM Gemini Therapeutics Announces $42.5 Million Series A Financing to Develop Precision Therapeutics in Ophthalmology and Rare Genetic Diseases
Oct 11, 2017 08:38AM PlacementTracker Publishes Q3 2017 Private Placement Market League Tables
Oct 5, 2017 03:48PM Form SC 13D/A Roka BioScience, Inc. Filed by: ORBIMED ADVISORS LLC
Oct 2, 2017 04:02PM Form SC 13D/A Roka BioScience, Inc. Filed by: ORBIMED ADVISORS LLC
Oct 2, 2017 09:00AM Brookline Capital Markets Announces a Major Expansion of Its Healthcare Investment Banking Services, Equity Research Department and Team
Sep 28, 2017 05:25PM Form SC 13D/A Roka BioScience, Inc. Filed by: ORBIMED ADVISORS LLC
Sep 27, 2017 04:00AM KaNDy Therapeutics Launched to Advance a Breakthrough Treatment in Women's Health
Sep 21, 2017 07:39AM ProMIS Neurosciences Independent Director Anthony J. Giovinazzo Recognized with Inaugural Bloom Burton Award for Innovation in Canadian Healthcare
Sep 20, 2017 08:00AM Inspire Medical Systems' Inspire Therapy for Reducing Obstructive Sleep Apnea Demonstrates Long-term Safety and Sustained Benefit Following 5 Years of Treatment
Sep 18, 2017 06:00AM Sonendo® Announces Growth Investment from General Atlantic
Sep 7, 2017 02:21PM Form SC 13D SYNLOGIC, INC. Filed by: ORBIMED ADVISORS LLC
Aug 23, 2017 05:18PM Form SC 13D/A Clementia Pharmaceutical Filed by: ORBIMED ADVISORS LLC
Aug 23, 2017 10:15AM Form SC 13D/A Roka BioScience, Inc. Filed by: ORBIMED ADVISORS LLC
Aug 22, 2017 08:00AM Avitide, Inc., Receives ISO 9001:2015 Certification for Its Affinity Resin Manufacturing Facility
Aug 15, 2017 05:07PM Form SC 13D/A SELECTA BIOSCIENCES INC Filed by: ORBIMED ADVISORS LLC
View More Recent Stories View Older Stories